Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Marvel Biosciences Corp V.MRVL

Alternate Symbol(s):  MBCOF

Healthcare Biotechnology
Marvel Biosciences Corp. is a Canada-based pre-clinical-stage pharmaceutical development biotechnology company. The Company develops new synthetic chemical derivatives of the original approved drug for the new disease indication. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs that inhibit the A2a adenosine receptor with... see more

Current News (TSXV:MRVL)

Marvel Biosciences Announces Grant of Deferred Share Units

Newsfile 13 hours ago

Marvel Biosciences Announces Acceleration of Warrant Expiry Date

Newsfile October 3, 2025

Marvel Biosciences Granted Chinese Patent for Lead Therapeutic Candidate MB-204

Newsfile August 18, 2025

Marvel Biosciences Announces Grant of Deferred Share Units

Newsfile August 11, 2025

Marvel Biosciences Announces Closing of Private Placement

Newsfile May 12, 2025

Marvel Biosciences Announces Closing of Second Tranche of Private Placement

Newsfile May 2, 2025

Marvel Announces the Second of Two Final Data Sets from Rett Syndrome Study: MB-204 Significantly Outperforms Trofinetide Following Cessation of Drug Treatment

Newsfile April 30, 2025

Marvel Biosciences to Give Oral Presentation at The Annual IRSF Rett Syndrome Scientific Meeting

Newsfile April 16, 2025

Marvel Biosciences Selected to Present Alzheimer's Research at the 2025 Alzheimer's Association International Conference

Newsfile April 14, 2025
View More News ››

Opinion & Analysis (TSXV:MRVL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:MRVL)

Thoughts on announced offering?

I was just shown this deal, anyone with any thoughts on it? Is it tied to Algernon pharma, that’s been huge loss and mess and loss of...
Whalewatcher1 - January 17, 2025

Marvel Biosciences Initiates Formulation Development

Calgary, Alberta--(Newsfile Corp. - April 6, 2022) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary...
Betteryear2 - April 6, 2022

Fox In The Hen House?

Check out the EHT forum and learn something.
suomynona - August 4, 2021
View more Bullboard ››

G Mining Ventures Corp.

G Mining Ventures Corp.

G Mining Ventures Corp. is a Canada-based mining company. The Company is engaged in the acquisition, exploration and ...
View More »